Paper · 34556502

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.

Wang Y and 12 others. J Med Genet, 2022. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing. Papers, record 34556502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34556502

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.; PubMed
Journal: J Med Genet; PubMed
Year: 2022; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/34556502/; PubMed
DOI: https://doi.org/10.1136/jmedgenet-2021-108054; PubMed
The journal: https://conductscience.org/library/journal-index/2985087R; PubMed
Citations, by iCite: 22; iCite
Relative citation ratio, by iCite: 1.48; iCite
Revised in PubMed: 2022-12-29; PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Wang Y	Yifan	https://orcid.org/0000-0003-2821-1953
2	Golesworthy B	Bryn
3	Cuggia A	Adeline
4	Domecq C	Celine
5	Chaudhury P	Prosanto
6	Barkun J	Jeffrey
7	Metrakos P	Peter
8	Asselah J	Jamil
9	Bouganim N	Nathaniel
10	Gao ZH	Zu-Hua

1 to 10 of 13Source PubMed

See all 13 authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Germ-Line Mutation	Major topic
Pancreatic Neoplasms	Major topic
Humans
Genetic Predisposition to Disease
Genetic Testing
Germ Cells
Prospective Studies

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMID	Title	Journal	Year	In Papers	Source
42,372,208	Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.	JCO Precis Oncol	2026	https://conductscience.org/library/papers/42372208	PubMed
42,118,569	Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.	Cancer	2026	https://conductscience.org/library/papers/42118569	PubMed
40,315,972	Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening.	Clin Gastroenterol Hepatol	2025	https://conductscience.org/library/papers/40315972	PubMed
39,938,008	Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.	JCO Precis Oncol	2025	https://conductscience.org/library/papers/39938008	PubMed
39,133,448	Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.	Ann Surg Oncol	2024	https://conductscience.org/library/papers/39133448	PubMed
39,102,633	Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma.	JCO Precis Oncol	2024	https://conductscience.org/library/papers/39102633	PubMed
38,573,398	Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC).	Fam Cancer	2024	https://conductscience.org/library/papers/38573398	PubMed
38,484,211	Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology.	JCO Precis Oncol	2024	https://conductscience.org/library/papers/38484211	PubMed
38,201,484	Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.	Cancers (Basel)	2023	https://conductscience.org/library/papers/38201484	PubMed
37,720,496	Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake.	Ther Adv Med Oncol	2023	https://conductscience.org/library/papers/37720496	PubMed

1 to 10 of 14

See all 14 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
UGT1A	7,361	PubTator's text mining	https://conductscience.org/library/genes/7361

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34556502

GET https://conductscience.org/api/papers/v1/34556502/authors

API reference For AI assistants